| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/22/2004 | WO2003089457A3 Peptide inhibitors of protein kinase c ϝ for pain management |
| 01/22/2004 | WO2003080792A3 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment |
| 01/22/2004 | WO2003076901A3 Methods of identifying target polypeptides |
| 01/22/2004 | WO2003075859A3 COMPOUNDS THAT MODULATE PROCESSES ASSOCIATED WITH IgE PRODUCTION AND METHODS AND KITS FOR IDENTIFYING AND USING THE SAME |
| 01/22/2004 | WO2003074990A9 Artificial receptors, building blocks, and methods |
| 01/22/2004 | WO2003070759A3 Method of modulating e-cadherin mediated cell adhesion |
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003065009A3 Methods and apparatus for assays of bacterial spores |
| 01/22/2004 | WO2003060521A3 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 01/22/2004 | WO2003058197A3 Detection of molecular interactions by beta-lactamase reporter fragment complementation |
| 01/22/2004 | WO2003055978A3 Gene recombination and hybrid protein development |
| 01/22/2004 | WO2003054213A3 Non-human primate fc receptors and methods of use |
| 01/22/2004 | WO2003050389A3 Apparatus and methods for downhole determination of characteristics of formation fluids |
| 01/22/2004 | WO2003050248A3 Adenine nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 01/22/2004 | WO2003049693A3 Method and composition for inducing weight loss |
| 01/22/2004 | WO2003048875A3 Method for guaranteeing at least one characteristic of a fluid used for producing food products |
| 01/22/2004 | WO2003044040A3 Alpha-fetoprotein peptides and uses thereof |
| 01/22/2004 | WO2003037257A3 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 01/22/2004 | WO2003037255A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319 |
| 01/22/2004 | WO2003036271A3 Identification of material inclusions in pulp and paper using raman spectroscopy |
| 01/22/2004 | WO2003035229A3 Integrated fluidic device for sample preparation and assay |
| 01/22/2004 | WO2003029479A3 Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids |
| 01/22/2004 | WO2003029285A3 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections |
| 01/22/2004 | WO2003027251A3 Novel molecules of the pyrin domain protein family and uses thereof |
| 01/22/2004 | WO2003020962A3 Method of identifying glycosyl transferase binding compounds |
| 01/22/2004 | WO2003020889A3 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
| 01/22/2004 | WO2003019195A3 Cellular immunity test with peptides fixed on a solid support |
| 01/22/2004 | WO2003018838A3 Interaction detection on several probe arrays |
| 01/22/2004 | WO2003014386A3 Method for identifying macrocyclic polyketides |
| 01/22/2004 | WO2003014380A3 Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/22/2004 | WO2003013234A3 Method for the in vivo screening of the biological activity of an acetylcholinesterase inhibitor compound on one or more cellular targets other than acetylcholinesterase |
| 01/22/2004 | WO2003004697A3 Method for detecting mutagenic substances |
| 01/22/2004 | WO2002099120A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/22/2004 | WO2002078643A3 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 01/22/2004 | WO2002070729A3 Improved skin substitutes and uses thereof |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | WO2002061203A3 Method and apparatus for measuring paper web formation |
| 01/22/2004 | US20040016035 Quality control of assays |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040015299 Clustering conformational variants of molecules and methods of use thereof |
| 01/22/2004 | US20040015102 Analyte testing device |
| 01/22/2004 | US20040015101 Rapid non-invasive method for differential acute cardiovascular disease diagnosis |
| 01/22/2004 | US20040015034 Purification to form clean liquid hydrocarbon fuels; preventing valve deposits, plugging of fuel filters |
| 01/22/2004 | US20040014981 Cyanine dyes |
| 01/22/2004 | US20040014975 For contraception, treatment of hormone-related (aging) conditions, and sexual dysfunction |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014946 Using mass spectroscopy to identify, reconstitute and determine the kinetics of multimeric polypeptide complexes; drug screening |
| 01/22/2004 | US20040014943 Antibodies for detecting microorganisms |
| 01/22/2004 | US20040014939 Comprises peptide with degratory activity for diagnosis, prevention and treatment of defects in vasodilation, hypotension and hypoglycemia |
| 01/22/2004 | US20040014779 Testing for immunology response moderators; viricides, antitumor agents |
| 01/22/2004 | US20040014760 4- (2-butylamino) -2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-YL) pyrazolo- [1,5-A] -1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/22/2004 | US20040014706 Using protein antagonist; therapy for congestive heart failure; blocking gene expression |
| 01/22/2004 | US20040014703 Aqueous solution containing cationic stabilizer |
| 01/22/2004 | US20040014702 Mammalian prostaglandin H synthase-2 |
| 01/22/2004 | US20040014701 Inhibiting retrotransposon and retroviral integration by targeting the atm pathway |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014664 Analyzing tumors; bone disorders; antidiabetic agents; platelet derived endothelial growth factor |
| 01/22/2004 | US20040014662 Modulation of neural stem cells and neural progenitor cells |
| 01/22/2004 | US20040014649 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014643 Method of structure-based drug design to create or improve modular of IL-1 activity which mind to the interleukin-1 type 1 receptor |
| 01/22/2004 | US20040014638 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014637 Mechanism for the inactivation of insulin receptor and uses in the treatment of type II diabetes |
| 01/22/2004 | US20040014636 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 01/22/2004 | US20040014242 An insoluble carrier having primary amino groups can be used as the carrier for absorptive immobilizations of a protein containing cysteine group, via ionic interection, then cyanating sulfhydryl group of cysteine with a cyanating agent |
| 01/22/2004 | US20040014241 Using microarrays to detect, monitor and screen biological activites of immobilized target proteins and peptides; colorimetric analysis |
| 01/22/2004 | US20040014237 Swab testing device and method |
| 01/22/2004 | US20040014235 Polymeric food spoilage sensor |
| 01/22/2004 | US20040014234 Measuring concentration of gas in solid sample using reducing furnace |
| 01/22/2004 | US20040014233 Thermal analysis for detection and identification of explosives and other controlled substances |
| 01/22/2004 | US20040014230 Diagnostic method for alzheimer's disease based on holo-transcobalamin II |
| 01/22/2004 | US20040014229 A protein or peptide to be analyzed is reacted with an acid (a pentafluoropropionic acid or heptafluorobutanoic acid, or fluorinated thioester, or hydrazine) for determining phosphosylation, sulfation and glycosylation |
| 01/22/2004 | US20040014226 Monitoring and analyzing swellability of lightly cross linked gels of acrylic acid and/salts; optical analysis |
| 01/22/2004 | US20040014223 Method intended for chemical and isotopic analysis and measurement on constituents carried by a drilling fluid |
| 01/22/2004 | US20040014222 Automated immunohistochemical and in situ hybridization assay formulations |
| 01/22/2004 | US20040014219 Comprises expression vector coding fusion protein associated cell proliferation and/or differentiation; gene therapy; animal model for disease |
| 01/22/2004 | US20040014208 Methods for culturing human lung mast cells and uses thereof |
| 01/22/2004 | US20040014206 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/22/2004 | US20040014203 Apparatus for collecting, processing and analyzing a liquid specimen; diagnostic testing for infectious diseases |
| 01/22/2004 | US20040014201 Biosensor microarray for detecting hybridized DNA; genetic analysis; disease prevention and detection; genetic analysis |
| 01/22/2004 | US20040014200 Method for chemiluminescent detection |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014163 Immunoassay mixture for measuring calcium-dependent glutamate dehydrogenase activities and treating bone, teeth and oral diseases |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014159 Methods and kits for transferases |
| 01/22/2004 | US20040014157 Obtaining accurate determination of analyte concentration in fluid test sample containing heterophilic antibodies with non-specific binding associatons; improving immunoasay sensitivity |
| 01/22/2004 | US20040014156 Comprises immunoglobulin which binds and can be utilized to determine concentration and/or accelerate clearance of polyethylene glycol containing compound; monitoring cell toxicity; immunotherapy; antitumor agents |
| 01/22/2004 | US20040014154 Methods and apparatus for assays of bacterial spores |
| 01/22/2004 | US20040014152 Lysing agent for use in analyzing blood and/or blood sample of non-human mammal; veterinary medicine; animal husbandry |
| 01/22/2004 | US20040014149 Relates to compounds that modulate processes associated with isotype switching of B cells and IgE production; treatment of diseases characterized by production or accumulation of IgE, including anaphylactic hypersensitivity, allergic reactions |
| 01/22/2004 | US20040014148 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 01/22/2004 | US20040014145 Monoclonal antibody with affinity to defective transferrin for diagnosing alcoholism; immunoassay |
| 01/22/2004 | US20040014144 Method of screening for substances acting on MSK1 |
| 01/22/2004 | US20040014142 Differential diagnosis of neurodegeneration |
| 01/22/2004 | US20040014140 Methods for identifying allosteric sites |
| 01/22/2004 | US20040014138 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 01/22/2004 | US20040014135 Molecules that modulate Galphaq avtivity and methods of treating urinary incontinence |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014133 Biotin-peg-substrate for a lipase assay |